Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials

<div>Meta-analysis for progression-free survival. CI: Confidence interval; HR: hazard ratio.</div>

Gastroenterology Research and Practice

Figure 3: Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials 